BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
See today's BioWorld
Home
» 'Generally a Thumbs-Up' as PDUFA V Heads to Congress
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
'Generally a Thumbs-Up' as PDUFA V Heads to Congress
June 20, 2012
By
Jennifer Boggs
No Comments
BOSTON – Lawmakers reached agreement late Monday on PDUFA V. The House is expected to pass the legislation, S. 3187, Wednesday, followed by the Senate late this week or early next week, coming in well ahead of their self-imposed July 4 goal.
BioWorld